Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Unknown 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Polycystic Ovary Syndrome 2Metabolic Syndrome 2Carcinoma, Non-Small-Cell Lung 2Sleep Apnea, Obstructive 1Pancreatic Neoplasms 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Insulin Resistance 1Inflammation 1Hypogonadism 1Glucose Intolerance 1Diabetes Mellitus 1

Interventions

Carboplatin 103Pemetrexed 96pembrolizumab 78Docetaxel 78Cisplatin 72Paclitaxel 70Erlotinib Hydrochloride 50Gemcitabine 48Radiotherapy 42Nivolumab 35Bevacizumab 35atezolizumab 24Radiosurgery 24durvalumab 20Cyclophosphamide 17130-nm albumin-bound paclitaxel 15Vinorelbine 14Taxes 14Radiation 14Etoposide 13Ipilimumab 12Albumin-Bound Paclitaxel 12avelumab 11Drug Therapy 10Cetuximab 10spartalizumab 9Sorafenib 9trametinib 8osimertinib 8capmatinib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Non-Small-Cell Lung × Pioglitazone × Clear all
NCT01342770 2017-12-05

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00923949 2015-09-30

Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
1 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡